Additionally, the suppression of AK3 (as a phosphotransferase and glycolysis-related gene) triggers a cancerous transformation, leading to an uncontrolled cell cycle and growth with a subsequently worse prognosis and shorter survival of patients with breast cancer (Klepinin et al., 2020; Chao et al., 2024). The gene discussed is AK3; the disease is breast carcinoma.